603585.SHG Suli Co Ltd
- Market cap
- CNY 2.58B
- P/E
- 24.0x
- P/B
- 0.88x
- ROE
- 2.5%
- Dividend yield
- 0.84%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603585.SHG undervalued?
Graham number603585.SHG trades 2.9% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Suli Co Ltd fundamental analysis
No fundamental analysis for Suli Co Ltd yet.
Suli Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Suli Co Ltd
Suli Co., Ltd. engages in the research, development, production, and sale of pesticides, flame retardants, and other fine chemical products in China and internationally. It offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane. The company also provides brominated, environment-friendly, and halogen-free flame retardants; and intermediates, including pentachloropyridine, …
Full company profileSuli Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Suli Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.35B | 1.46B | 1.65B | 1.81B | 1.56B | 2.35B | 3.15B | 1.96B | 2.31B | 2.78B | 2.71B |
| Gross Profit | 483M | 584M | 665M | 662M | 417M | 549M | 676M | 243M | 266M | 595M | 484M |
| Operating Income | 303M | 366M | 508M | 486M | 261M | 342M | 458M | 24.1M | -15.4M | 319M | 197M |
| EBITDA | 347M | 501M | 566M | 538M | 338M | 443M | 594M | 177M | 256M | 618M | 161M |
| Net Income | 185M | 225M | 312M | 303M | 175M | 241M | 315M | 20.1M | -10.8M | 193M | 73.2M |
| EPS | 1.33 | 1.25 | 1.73 | 1.68 | 0.97 | 1.34 | 1.49 | 0.11 | -0.06 | 0.74 | 0.27 |
| Balance Sheet | |||||||||||
| Total Assets | 1.90B | 2.04B | 2.46B | 2.85B | 3.07B | 3.87B | 5.31B | 5.69B | 5.74B | 5.75B | 5.79B |
| Total Liabilities | 260M | 158M | 224M | 317M | 548M | 1.17B | 1.97B | 2.48B | 2.55B | 2.32B | 2.16B |
| Shareholders' Equity | 1.34B | 1.52B | 1.76B | 1.96B | 2.03B | 2.20B | 2.62B | 2.48B | 2.47B | 2.70B | 2.88B |
| Cash & Short-term Investments | 921M | 1.01B | 1.24B | 1.26B | 1.08B | 1.14B | 1.94B | 1.33B | 733M | 409M | 318M |
| Total Debt | 92.5M | - | 17.7M | 61.9M | 94.7M | 41.3M | 904M | 1.08B | 1.30B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 237M | 285M | 420M | 486M | 169M | 316M | 519M | 216M | -41.7M | 399M | - |
| Capital Expenditure | 107M | 84.2M | 140M | 384M | 215M | 291M | 604M | 661M | 699M | 512M | 390M |
| Free Cash Flow | 130M | 200M | 281M | 103M | -46.0M | 24.6M | -84.2M | -445M | -741M | -113M | -74.6M |
| Ratios | |||||||||||
| ROE | 13.8% | 14.8% | 17.7% | 15.5% | 8.6% | 11.0% | 12.1% | 0.8% | -0.4% | 7.1% | 2.5% |
| ROA | 9.8% | 11.0% | 12.7% | 10.6% | 5.7% | 6.2% | 5.9% | 0.4% | -0.2% | 3.4% | 1.3% |
| Net Profit Margin | 13.7% | 15.4% | 19.0% | 16.7% | 11.2% | 10.3% | 10.0% | 1.0% | -0.5% | 6.9% | 2.7% |
| Debt to Equity | 0.07x | - | 0.01x | 0.03x | 0.05x | 0.02x | 0.35x | 0.44x | 0.53x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Suli Co Ltd dividends
- Dividend yield
- 0.84%
- Forward dividend
- 0.36 CNY
- Payout ratio
- 11.2%
- Ex-dividend date
- Jul 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 21.7M | 0.08 | 11.2% |
| 2024 | CNY 54.9M | 0.30 | - |
| 2023 | CNY 99.0M | 0.54 | 493.1% |
| 2022 | CNY 65.7M | 0.31 | 20.8% |
| 2021 | CNY 54.0M | 0.30 | 22.4% |
| 2020 | CNY 108M | 0.60 | 61.8% |
| 2019 | CNY 108M | 0.60 | 35.6% |
| 2018 | CNY 75.0M | 0.42 | 24.0% |
| 2017 | CNY 71.2M | 0.40 | 31.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jul 9, 2026.
Who owns Suli Co Ltd
- Insiders 65.69%
- Institutions 0.42%
- Public & others 33.89%
- Shares outstanding 275M
- Free float 114M
Suli Co Ltd company profile
- Company name
- Suli Co Ltd
- Ticker
- 603585.SHG
- ISIN
- CNE100002G35
- Exchange
- Shanghai Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,898
- Fiscal year end
- December
- Address
- No.7-1, Runhua Road, Jiangyin, China, 214444
- Phone
- 86 510 8663 1388
- Website
- suli.com
About Suli Co Ltd
Suli Co., Ltd. engages in the research, development, production, and sale of pesticides, flame retardants, and other fine chemical products in China and internationally. It offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane. The company also provides brominated, environment-friendly, and halogen-free flame retardants; and intermediates, including pentachloropyridine, pentachlorobenzonitrile, isophthalonitrile, and hydrobromic acid, as well as diphenylethane and 1,2-dibromoethane. In addition, it offers industry biocides, such as Longee 985CHL, 550CCD, 550CC, and 500CHL; and calcium chloride and ferric chloride solution for use in water treatment. The company sells its products under the Suli brand name for use in agricultural production, plastics and building materials industries, medicine, and other fields. Suli Co., Ltd. was founded in 1994 and is headquartered in Jiangyin, China.
Suli Co Ltd management
6- Ms. Jing Li WangChairman & GM · born 1981
- Mr. Gang LiCFO & In Charge of Accounting Department · born 1978
- Mr. Hai Feng SunDeputy GM & Director · born 1974
- Mr. Dawen WangChief Engineer & Director · born 1971
- Mr. Zhe ZhangBoard Secretary · born 1989
- Mr. Cheng ChangDeputy General Manager · born 1985